Lenvatinib inhibits intrahepatic cholangiocarcinoma via Gadd45a-mediated cell cycle arrest

PURPOSE: To evaluate the anticancer activities of lenvatinib in ICC and its possible molecular mechanisms. METHODS: Patients-derived xenograft (PDX) model and cell line-derived xenograft (CDX) model were both used for the in vivo study. For in vivo work, ICC cell lines were applied to analyze the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Xia, Wang, Dan, Ning, Zhouyu, Meng, Zhi-qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950313/
https://www.ncbi.nlm.nih.gov/pubmed/36821012
http://dx.doi.org/10.1007/s12672-023-00631-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950313/
https://www.ncbi.nlm.nih.gov/pubmed/36821012
http://dx.doi.org/10.1007/s12672-023-00631-4

Ejemplares similares